Publication:
Prevalance of Anti-HCV among Hemodialysis and CAPD Patients

Simple item page
dc.contributor.authorBaskol M.
dc.contributor.authorAkpolat T.
dc.contributor.authorBedir A.
dc.contributor.authorGunaydin M
dc.contributor.authorMalazgirt Z.
dc.contributor.authorKamali A.
dc.date.accessioned2020-06-21T09:19:22Z
dc.date.available2020-06-21T09:19:22Z
dc.date.issued1997
dc.departmentOMÜen_US
dc.department-tempBaskol, M., Ondokuz Mayis Universitesi, Tip Fakultesi, Hastaliklari Anabilim Dali, 55139 Kurupelit, Samsun, Turkey -- Akpolat, T., Ondokuz Mayis Universitesi, Tip Fakultesi, Hastaliklari Anabilim Dali, 55139 Kurupelit, Samsun, Turkey -- Bedir, A., Ondokuz Mayis Universitesi, Tip Fakultesi, Hastaliklari Anabilim Dali, 55139 Kurupelit, Samsun, Turkey -- Gunaydin M, Ondokuz Mayis Universitesi, Tip Fakultesi, Hastaliklari Anabilim Dali, 55139 Kurupelit, Samsun, Turkey -- Malazgirt, Z., Ondokuz Mayis Universitesi, Tip Fakultesi, Hastaliklari Anabilim Dali, 55139 Kurupelit, Samsun, Turkey -- Kamali, A., Ondokuz Mayis Universitesi, Tip Fakultesi, Hastaliklari Anabilim Dali, 55139 Kurupelit, Samsun, Turkey --en_US
dc.description.abstractHCV infection is the most common cause of liver disease among dialysis patients. Patients with end stage renal disease are at risk of acquiring HCV infection from blood product transfusions, intravenous access or other patients in dialysis units. Continuous ambulatory peritoneal dialysis is getting popular among dialysis patients in our country. The aim of this study is to demonstrate anti-HCV frequency, liver enzyme levels and blood transfusion numbers among hemodialysis and CAPD patients. 41 hemodialysis patients (19 male, 22 female, mean age 36.6 years, mean hemodialysis duration 55.2 months) and 24 CAPD patients (7 male, 17 female, mean age 46.4 years, mean CAPD duration 10.0 months) were included to the study. This study shows the prevalence of anti-HCV and number of blood transfusion is lower in CAPD patients than in hemodialysis patients.en_US
dc.identifier.endpage268en_US
dc.identifier.issn1300-2996
dc.identifier.issue4en_US
dc.identifier.startpage265en_US
dc.identifier.urihttps://hdl.handle.net/20.500.12712/2993
dc.identifier.volume14en_US
dc.language.isotren_US
dc.relation.journalOndokuz Mayis Universitesi Tip Dergisien_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.subjectAnti-HCVen_US
dc.subjectContinuous Ambulatory Peritoneal Dialysisen_US
dc.subjectHemodialysisen_US
dc.titlePrevalance of Anti-HCV among Hemodialysis and CAPD Patientsen_US
dc.title.alternativeHEMODIYALIZ VE SAPD HASTALARINDA ANTI-HCV SIKLIGIen_US
dc.typeArticleen_US
dspace.entity.typePublication

Files

Collections

Scopus İndeksli Yayınlar Koleksiyonu